Background: Dominant-intermediate Charcot-Marie-Tooth neuropathy subtype C (DI-CMTC) is associated with mutations in the YARS gene. The aim of this study is to investigate the long-term natural history of the disease.
Methods: In a 5-generation DI-CMTC family, we compared data from 2016 to that of 2000 in 13 of 21 original participants.
Results: Five women and 8 men were examined. While most symptoms and signs progressed, only gait progression was statistically significant (P = .016). The median CMT Neuropathy Score was 6.08 in 2000 and 11 in 2016 (P = .001). Quality of life (QOL) deteriorated in mobility (P = .008), pain/discomfort (P = .011), and anxiety/depression (P = .014). Median and ulnar compound muscle action potential amplitudes decreased from 9.35 ± 2.90 mV to 6.0 ± 2.9 mV (P = .002), and from 9.24 ± 2.10 mV to 6.06 ± 1.81 mV (P = .004), respectively, whereas motor nerve conduction velocities remained unchanged.
Conclusions: DI-CMTC in this family is a slowly progressive disease with axonal degeneration, deteriorating mobility and QOL.
Keywords: YARS gene; Aminoacyl-tRNA synthetase; CMTNSv2; Charcot-Marie-Tooth disease; autosomal dominant; intermediate conduction velocities.
© 2019 Wiley Periodicals, Inc.